"Metaphilic" Cell-Penetrating Polypeptide-Vancomycin Conjugate Efficiently Eradicates Intracellular Bacteria via a...

Area of Science:

• Microbiology
• Drug Delivery
• Bioconjugation

Background:

• Intracellular bacterial infections pose treatment challenges due to limited antibiotic access within host cells.
• Developing strategies to enhance antibiotic penetration into host cells is crucial for improving efficacy against intracellular pathogens.

Purpose of the Study:

• To design and evaluate an adaptive, metaphilic cell-penetrating polypeptide (CPP)-antibiotic conjugate (VPP-G) for eradicating intracellular bacteria.
• To investigate the mechanism of action and efficacy of VPP-G against various bacterial strains, including drug-resistant ones.

Main Methods:

• Synthesis of VPP-G by conjugating vancomycin to a guanidinium-functionalized metaphilic CPP.
• In vitro and in vivo testing of VPP-G against extracellular and intracellular pathogens like Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci.
• Analysis of VPP-G's membrane penetration mechanism and its effects on bacterial cell wall biosynthesis and membrane integrity.

Main Results:

• VPP-G demonstrated potent activity against both extracellular and intracellular bacteria, including MRSA and vancomycin-resistant Enterococci.
• The conjugate utilizes a unique metaphilic membrane penetration mechanism to enter host cells.
• VPP-G exhibited superior in vivo efficacy against MRSA compared to vancomycin alone, highlighting its potential.

Conclusions:

• The developed VPP-G conjugate offers a promising therapeutic strategy for combating intracellular bacterial infections.
• The dual antimicrobial mechanism of VPP-G, targeting cell wall biosynthesis and membrane integrity, may prevent resistance development and combat dormant bacteria.
• This adaptable CPP-antibiotic conjugation strategy can be extended to develop novel treatments for other intracellular pathogens.